CPHI - China Pharma Holdings, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue12,330.68713,212.31415,570.51420,351.63
Cost of Revenue10,355.83910,743.76412,352.00418,887.069
Gross Profit1,974.8482,468.553,218.511,464.561
Operating Expenses
Research Development172.38490.474365.969961.897
Selling General and Administrative5,166.4335,480.5456,302.4416,191.198
Non Recurring----
Others---343.023-1,640.531
Total Operating Expenses16,299.04417,708.35919,763.8434,546.926
Operating Income or Loss-3,968.357-4,496.045-4,193.326-14,195.296
Income from Continuing Operations
Total Other Income/Expenses Net-6,891.799-14,658.889-4,681.123-1,149.783
Earnings Before Interest and Taxes-3,968.357-4,496.045-4,193.326-14,195.296
Interest Expense-451.258-539.334-849.557-1,165.164
Income Before Tax-10,860.156-19,154.934-8,874.449-15,345.079
Income Tax Expense-109.989122.631308.17560.439
Minority Interest----
Net Income From Continuing Ops-10,750.167-19,277.565-9,182.624-15,405.518
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,750.167-19,277.565-9,182.624-15,405.518
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,750.167-19,277.565-9,182.624-15,405.518